PulseAugur
EN
LIVE 11:19:49
中文(ZH) 药明康德:6月23日回购93.24万股A股,耗资1.00亿元

WuXi AppTec repurchases shares; JD Pharmacy increases capital; new LLM emerges

WuXi AppTec announced on June 23rd that it repurchased 932,400 A-shares for approximately 100 million yuan. These shares are intended for an employee stock ownership plan. In a separate development, JD Pharmacy's Jiangsu subsidiary increased its registered capital from 10 million to 20 million yuan. The news flash also briefly mentioned a new large model claiming parity with Fable 5 and Mythos, alongside other unrelated news items. AI

IMPACT A new large model is claimed to rival existing benchmarks, but details are scarce, suggesting potential but unconfirmed advancements.

RANK_REASON The item is a news digest with multiple unrelated topics, including a minor stock repurchase and a capital increase, with a brief mention of a new LLM without primary source details, making it low-value aggregation.

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

WuXi AppTec repurchases shares; JD Pharmacy increases capital; new LLM emerges

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    WuXi AppTec: Bought back 932,400 A-shares on June 23, costing 100 million yuan

    36氪获悉,药明康德公告称,公司6月23日实施股份回购,于上海证券交易所回购932,400股A股,每股最高购回价109.18元,最低105.76元,付出价格总额100,009,235元,所回购A股将用于员工持股计划。此次回购后,公司已发行股份(不包括库存股份)数目变为2,465,307,865股,库存股份数目变为7,972,381股。